Impairment Risk from Price Fluctuations in Shares and Business-Use Real Estate
First written in FY2017. 15 of 29 entries say "Mitigated", first in FY2020-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2019: 10 of 23 companies on the "Worse" side.
3 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Valuation differences on available-for-sale securities 3,589 4,526」
Valuation differences on available-for-sale securities increased from ¥3,589 million at the end of the previous fiscal year to ¥4,526 million. No securities impairment was reported for the current fiscal year. - FY2026-H1MitigatedAnnual report
「Valuation differences on available-for-sale securities 3,589 4,355」
Valuation differences on available-for-sale securities increased from ¥3,589 million at the end of the previous fiscal year to ¥4,355 million, indicating an improvement from the decline in valuation differences and securities impairment reported in the previous fiscal year. - FY2025WorsenedAnnual report
「Valuation differences on available-for-sale securities 3,954 3,589」
Valuation differences on available-for-sale securities decreased from ¥3,954 million at the end of the previous fiscal year to ¥3,589 million. Impairment of ¥2 million was also recognised for unlisted shares. - FY2025-H1WorsenedAnnual report
「Valuation differences on available-for-sale securities 3,954 3,638」
Valuation differences on available-for-sale securities decreased by ¥316 million from ¥3,954 million at the end of the previous consolidated fiscal year to ¥3,638 million. The interim consolidated statement of comprehensive income also showed a ¥315 million decrease in valuation differences on available-for-sale securities. - FY2024MitigatedAnnual report
「3. Securities subject to impairment No applicable items.」
There was no securities impairment during the current fiscal year, while valuation differences on available-for-sale securities increased from ¥3,261 million to ¥3,954 million. - FY2024-Q3MitigatedAnnual report
「Valuation differences on available-for-sale securities 3,261 4,146」
Valuation differences on available-for-sale securities increased from ¥3,261 million at the end of the previous consolidated fiscal year to ¥4,146 million. - FY2024-Q2MitigatedAnnual report
「Valuation differences on available-for-sale securities 3,261 3,389」
Valuation differences on available-for-sale securities increased from ¥3,261 million at the end of the previous consolidated fiscal year to ¥3,389 million. - FY2024-Q1MitigatedAnnual report
「Valuation differences on available-for-sale securities 3,261 3,418」
Valuation differences on available-for-sale securities increased from ¥3,261 million at the end of the previous consolidated fiscal year to ¥3,418 million at the end of the first quarter of the current fiscal year. - FY2023MitigatedAnnual report
「Valuation differences on available-for-sale securities 2,417 3,261」
Valuation differences on available-for-sale securities increased from ¥2,417 million at the end of the previous fiscal year to ¥3,261 million. No securities impairment was recorded during the current fiscal year, with the disclosure stating that there were no applicable items. - FY2023-Q2WorsenedAnnual report
「Valuation differences on available-for-sale securities 2,417 2,387」
Valuation differences on available-for-sale securities decreased by ¥30 million from ¥2,417 million at the end of June 2022 to ¥2,387 million at the end of December 2022. The impact of fluctuations in the prices of held shares and other securities on valuation was modest. - FY2023-Q1RestatedAnnual report
「Nothing newly arose during the cumulative first quarter of the current consolidated fiscal year. There have also been no material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding impairment risk from fluctuations in the prices of shares and business-use real estate. - FY2022-Q3RestatedAnnual report
「Valuation differences on available-for-sale securities 2,364 2,561」
Valuation differences on available-for-sale securities increased from ¥2,364 million at the end of the previous consolidated fiscal year to ¥2,561 million, maintaining a level opposite to the decline in the fair value of held shares that emerged in the previous fiscal year. - FY2022-Q2MitigatedAnnual report
「Valuation differences on available-for-sale securities 2,364 2,581」
Valuation differences on available-for-sale securities increased from ¥2,364 million at the end of the previous consolidated fiscal year to ¥2,581 million at the end of the second quarter of the current fiscal year, continuing to move in the opposite direction from the decline in the fair value of held shares and impairment that emerged in the previous fiscal year. - FY2022-Q1MitigatedAnnual report
「Valuation differences on available-for-sale securities 2,364 2,555」
Valuation differences on available-for-sale securities increased from ¥2,364 million at the end of the previous consolidated fiscal year to ¥2,555 million at the end of the first quarter of the current fiscal year. This indicates a change in the opposite direction from the risk of securities impairment that emerged in the previous fiscal year. - FY2021WorsenedAnnual report
「During the current consolidated fiscal year, impairment of ¥113 million was recognised for available-for-sale securities. For impairment purposes, securities are impaired when their fair value at the end of the fiscal year has declined by 30% or more from acquisition cost.」
Regarding the risk of fluctuations in the prices of held shares and other securities, impairment of ¥113 million on securities occurred during the current fiscal year. The impairment amount increased from ¥46 million in the previous fiscal year. - FY2021-Q3MitigatedAnnual report
「Valuation differences on available-for-sale securities 1,835 2,517」
Valuation differences on available-for-sale securities increased from ¥1,835 million at the end of the previous consolidated fiscal year to ¥2,517 million as the fair value of held shares rose. The change continues to move in the opposite direction from the decline in the fair value of held shares that emerged in the previous fiscal year. - FY2021-Q2MitigatedAnnual report
「Valuation differences on available-for-sale securities 1,835 2,144」
Valuation differences on available-for-sale securities increased from ¥1,835 million at the end of the previous consolidated fiscal year to ¥2,144 million at the end of the second quarter of the current fiscal year. The change continues to move in the opposite direction from the decline in the fair value of held shares that emerged in the previous fiscal year. - FY2021-Q1MitigatedAnnual report
「Valuation differences on available-for-sale securities 1,835 2,042」
Valuation differences on available-for-sale securities increased from ¥1,835 million at the end of the previous consolidated fiscal year to ¥2,042 million at the end of the first quarter of the current fiscal year. This indicates a change in the opposite direction from the decline in the fair value of held shares that emerged in the previous fiscal year. - FY2020WorsenedAnnual report
「During the current consolidated fiscal year, impairment of ¥46 million was recognised for available-for-sale securities, comprising unlisted shares.」
Regarding the risk of fluctuations in the prices of held shares and other securities, impairment of ¥46 million on unlisted shares actually occurred during the current consolidated fiscal year. Valuation differences on available-for-sale securities also decreased from ¥2,237 million to ¥1,835 million. - FY2020-Q3WorsenedAnnual report
「Net assets increased by ¥2,184 million from the end of the previous consolidated fiscal year to ¥80,292 million. This was because valuation differences on available-for-sale securities decreased as the fair value of held shares declined, while retained earnings increased as quarterly net income attributable to owners of the parent exceeded dividend payments.」
The decline in the fair value of held shares was reported again, resulting in a decrease in valuation differences on available-for-sale securities. An investment securities valuation loss of ¥63 million was also recorded as an extraordinary loss. - FY2020-Q2MitigatedAnnual report
「Net assets increased by ¥2,411 million from the end of the previous consolidated fiscal year to ¥80,520 million. This was because retained earnings increased as quarterly net income attributable to owners of the parent exceeded dividend payments. Valuation differences on available-for-sale securities also increased as the fair value of held shares rose.」
Unlike the decline in the fair value of held shares reported through the previous quarter, valuation differences on available-for-sale securities increased from ¥2,237 million to ¥2,857 million this time as the fair value of held shares rose. - FY2019-Q3WorsenedAnnual report
「Assets at the end of the third quarter of the current consolidated fiscal year increased by ¥2,652 million from the end of the previous consolidated fiscal year to ¥93,628 million. This was because cash and deposits and securities decreased to fund construction payments, and investment securities decreased as the fair value of held shares declined, while notes receivable, accounts receivable from completed construction contracts and other items increased as construction progressed.」
The disclosure that investment securities decreased because the fair value of held shares declined continues. Investment securities decreased from ¥20,033 million at the end of the previous consolidated fiscal year to ¥18,372 million, while valuation differences on available-for-sale securities decreased from ¥3,028 million to ¥2,323 million. - FY2019-Q2WorsenedAnnual report
「Assets at the end of the second quarter of the current consolidated fiscal year decreased by ¥2,253 million from the end of the previous consolidated fiscal year to ¥88,722 million. This was because notes receivable, accounts receivable from completed construction contracts and other items increased as construction projects became larger, while cash and deposits and securities decreased to fund construction payments. Investment securities also decreased because the fair value of held shares declined.」
The Company states that a decline in the fair value of held shares actually occurred, resulting in a decrease in investment securities. As no impairment loss is reported, this is recorded as the materialisation of a decline in market prices. - FY2019-Q1RestatedAnnual report
「Nothing newly arose during the cumulative first quarter of the current consolidated fiscal year. There have also been no material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding impairment risk from fluctuations in the prices of shares and business-use real estate. - FY2018-Q3RestatedAnnual report
「Nothing newly arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding impairment risk from fluctuations in the prices of shares and business-use real estate. - FY2018-Q1RestatedAnnual report
「Nothing newly arose during the cumulative first quarter of the current consolidated fiscal year. There have also been no material changes to the "Business and Other Risks" described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding impairment risk from fluctuations in the prices of shares and business-use real estate. - FY2017First statedAnnual report
「As our Group holds shares and other securities and business-use real estate, a substantial future decline in their fair value could subject them to impairment and affect business performance.」
The Company identifies as a risk the impairment and impact on business performance resulting from declines in the fair value of held shares and other securities and business-use real estate.